COMBINATION OF ORGANIC COMPOUNDS

摘要

The invention relates to a pharmaceutical combination comprising an AT1 receptor blocker or pharmaceutically acceptable salts thereof and a compound which exhibits advanced glycosylation end product (AGE) breaking activity (also called AGE breaker)or a pharmaceutically effective salts thereof, optionally in the presence of a pharmaceutically acceptable carrier.